CASI Pharmaceuticals, Inc. (CASI) Earning

NASDAQ Currency in USD Disclaimer

$2.65

south_east -$0.14 (-5.02%)
Day's range
$2.65
Day's range
$2.82

CASI Pharmaceuticals, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$0.05 -$0.05 -$0.05
Q2 2024 1 -$0.63 -$0.63 -$0.63
Q3 2024 1 -$0.62 -$0.62 -$0.62
Q4 2024 1 -$0.60 -$0.60 -$0.60
Q1 2025 1 -$0.61 -$0.61 -$0.61
Q2 2025 1 -$0.54 -$0.54 -$0.54
Q3 2025 1 -$0.51 -$0.51 -$0.51
Q4 2025 1 -$0.47 -$0.47 -$0.47

CASI Pharmaceuticals, Inc. Earnings Date And Information

CASI Pharmaceuticals, Inc. last posted its earnings results on Friday, November 15th, 2024. The company reported $-0.55 earnings per share for the quarter, topping analysts' consensus estimates of $-0.62 by $0.07. The company had revenue of 7.79 M for the quarter and had revenue of 33.88 M for the year. CASI Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-2.02 diluted earnings per share) and currently has a price-to-earnings ratio of -1.34. CASI Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.

CASI Pharmaceuticals, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
09/30/2024 Q3 2024 -$0.55 $4.56 M $7.79 M
06/28/2024 Q2 2024 -$0.52 $4.43 M $3.98 M
03/29/2024 Q1 2024 -$0.71 $3.41 M
03/28/2024 Q4 2023 -$0.24 -$0.41 -0.17 $6.09 M
09/29/2023 Q3 2023 -$0.35 $10.43 M $8.84 M
06/29/2023 Q2 2023 -$0.77 $10.09 M $9.82 M
03/30/2023 Q1 2023 -$0.45 $8.35 M
04/26/2023 Q4 2022 -$0.64 -$1.37 -0.73 $15.26 M
11/14/2022 Q3 2022 -$0.51 -$0.28 0.23 $9.91 M $10.21 M
08/12/2022 Q2 2022 -$0.65 -$0.56 0.09 $7.87 M $8.57 M
05/12/2022 Q1 2022 -$1.00 -$0.70 0.3 $9.06 M
03/28/2022 Q4 2021 -$0.60 -$0.04 0.56 $9.16 M
11/12/2021 Q3 2021 -$0.60 -$0.73 -0.13 $7.53 M $8.11 M
08/12/2021 Q2 2021 -$0.50 $6.02 M $7.16 M
05/13/2021 Q1 2021 -$0.50 -$1.11 -0.61 $5.74 M
03/30/2021 Q4 2020 -$0.70 -$0.12 0.58 $4.82 M
11/09/2020 Q3 2020 -$0.60 -$1.44 -0.84 $3.44 M $4.24 M
08/10/2020 Q2 2020 -$0.80 -$0.86 -0.06 $3.75 M $2.67 M
05/11/2020 Q1 2020 -$1.10 -$0.85 0.25 $3.41 M
03/16/2020 Q4 2019 -$1.10 -$0.13 0.97 $1.34 M
 

CASI Pharmaceuticals, Inc. Earnings: FAQ's

When is CASI Pharmaceuticals, Inc.'s earnings date?

CASI Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.

Did CASI Pharmaceuticals, Inc. beat their earnings estimates last quarter?

In the previous quarter, CASI Pharmaceuticals, Inc. (:CASI) reported $-0.55 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.62 by $0.07.

How can I listen to CASI Pharmaceuticals, Inc.'s earnings conference call?

The conference call for CASI Pharmaceuticals, Inc.'s latest earnings report can be listened to online.

How can I read CASI Pharmaceuticals, Inc.'s conference call transcript?

The conference call transcript for CASI Pharmaceuticals, Inc.'s latest earnings report can be read online.

How much revenue does CASI Pharmaceuticals, Inc. generate each year?

CASI Pharmaceuticals, Inc. (:CASI) has a recorded annual revenue of $33.88 M.

How much profit does CASI Pharmaceuticals, Inc. generate each year?

CASI Pharmaceuticals, Inc. (:CASI) has a recorded net income of $33.88 M. CASI Pharmaceuticals, Inc. has generated $-2.02 earnings per share over the last four quarters.

What is CASI Pharmaceuticals, Inc.'s price-to-earnings ratio?

CASI Pharmaceuticals, Inc. (:CASI) has a price-to-earnings ratio of -1.34 and price/earnings-to-growth ratio is 0.13.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED